ScholarWorks@Korea University: Kang, Seok Ho

Detailed Information

Kang, Seok Ho (강석호)

College of Medicine (Department of Medical Science)

Research Area

Tel 안5367
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Renal cell carcinoma:16||Survival:13||Nephrectomy:11||Prognosis:11||Robotics:7||prognosis:6||Laparoscopy:6||Recurrence:6||renal cell carcinoma:6||Cystectomy:5||Urinary bladder neoplasms:5||Prostatic neoplasms:5||nephrectomy:4||carcinoma:4||survival:4||Cryosurgery:4||Kidney neoplasms:3||robotics:3||learning curve:3||kidney:3||renal insufficiency:3||renal cell:3||Body mass index:2||Transitional cell carcinoma:2||Chemotherapy:2||chronic:2||prostate cancer:2||Urinary diversion:2||Treatment outcome:2||Prostatectomy:2||Prostatespecific antigen:2||partial nephrectomy:2||Histology:2||Urothelial carcinoma:2||urothelial carcinoma:2||Urothelial cell carcinoma:2||Cholesterol:2||pain:2||Partial nephrectomy:2||bladder cancer:2||body mass index:2||Nephroureterectomy:2||nephroureterectomy:2||Prostate cancer:2||Kidney:2||recurrence:2||Neoplasm metastasis:2||Carcinoma:2||Transperineal biopsy:1||Nonspecific binding:1||multicenter study:1||Malignant disease:1||Age groups:1||Learning curve:1||Obesity:1||education:1||Transurethral resection of the prostate:1||Urinary bladder:1||MVAC protocol:1||RCC:1||Prostate:1||Mammalian target of rapamycin inhibitor:1||Multiinstitutional study:1||Urine alkalinization:1||biopsy:1||Chronic kidney disease:1||Renal cell:1||PROSTATE CANCER:1||intracorporeal urinary diversion:1||Protein blocking layer:1||Biosensor:1||Prostate neoplasms:1||Urological neoplasm:1||Renal Insufficiency:1||age:1||Kidney cancer:1||thrombocytosis:1||Hypercholesterolemia:1||Age:1||living donors:1||Acute prostatitis:1||Extended spectrum betalactamase:1||Cisplatin failure:1||Chronic renal insufficiency:1||Clear cell renal carcinoma:1||survival rate:1||disposable sensor chips:1||Multidetector Computed Tomography:1||pRCC:1||DU145 CELLS:1||pentafecta:1||Magnetic resonance imaging:1||Serum:1||Carcinoma, renal cell:1||obesity:1||anxiety:1||Bladder Cancer:1||Urothelial Carcinoma:1||T1b:1||Database:1||DOPA:1||Computer simulation:1||Urinary Bladder Neoplasms:1||Neoadjuvant Therapy:1||Transrectal prostate biopsy:1||kidney function tests:1||microRNA:1||HEAL NEOBLADDER:1||BLADDERCANCER:1||Pheochromocytoma:1||Bladder:1||Tuberous sclerosis:1||Ultrasonography:1||Immunotherapy:1||KORCC database:1||HORMONE THERAPY:1||CELL PROLIFERATION:1||Robotic surgical procedures:1||Androgen deprivation therapy:1||Healthrelated quality of life:1||Transurethral resection of prostate:1||Alanine transaminase:1||Aspartate aminotransferase:1||simulator:1||Benign prostatic hyperplasia:1||Neoplasm:1||Tuberous sclerosis complex:1||VALIDATION:1||Angiomyolipoma:1||bladder:1||lymphovascular invasion:1||Body fluidimmiscible tissue adhesive:1||Warm ischemia:1||Intraabdominal Fat:1||uric acid stone:1||da Vinci Single Port:1||upper urinary tract:1||prediction model:1||Pathology, surgical:1||predictive value:1||Transitional cell cancer:1||urodynamics:1||Ureteral calculus:1||Metastasis:1||Renal Cell Carcinoma:1||perioperative blood transfusion:1||Mussel adhesive proteins:1||Complex coacervation:1||Gleason score:1||Neoplasms:1||retrospective studies:1||Adrenalectomy:1||Laminin 332:1||Gemcitabine and carboplatin:1||acute urinary retention:1||benign prostatic hyperplasia:1||magnetic resonance imaging:1||Kidney collecting tubules:1||outcomes assessment:1||Cryoablation:1||urachal carcinoma:1||Mussel adhesive protein:1||graphenebased electrical sensor:1||patient urine:1||GONADOTROPINRELEASING HORMONE (GNRH) AGONIST:1||urinary stone:1||robotassisted radical cystectomy (RARC):1||Fieldeffect transistor:1||Comorbidity:1||Urothelium:1||cholesterol:1||Renal Cell:1||Radical Cystectomy:1||margin:1||Population characteristics:1||Underwater adhesion:1||Adjuvant:1||Renal insufficiency:1||Propensity score:1||Complementary therapies:1||Overactive bladder:1||kidney neoplasms:1||pathology:1||radical nephrectomy:1||Everolimus:1||risk factors:1||Invasion:1||Elderly:1||SURGERY:1||LeschNyhan syndrome:1||prostatic neoplasms:1||Biopsy:1||Functional regeneration:1||Kidney Neoplasm:1||GNRH TYPE 1 RECEPTOR:1||Combined androgen blockade:1||gender:1||Cancer survivors:1||thermotherapy:1||Sex:1||cystectomy:1||Bladder outlet obstruction:1||Ureteral stent:1||Diabetes mellitus:1||Urinary fistula:1||prostate neoplasms:1||Neoplasm invasiveness:1||Postoperative complication:1||papillary:1||Secondline:1||prostate:1||sedation:1||neoplasm staging:1||radical prostatectomy:1||surgical margin:1||clinical diagnosis:1||labelfree detection:1||T stage:1||Luteinizing hormonereleasing hormone agonist:1||Quality of life:1||Androgen antagonists:1||Minimally invasive surgical procedures:1||Depression:1||Outcomes:1||transitional cell:1||Prostatic hyperplasia:1||Stone disease:1||Nephronsparing surgery:1||chronic renal insufficiency:1||followup studies:1||Cryotherapy:1||incidence:1||CYSTOPROSTATECTOMY:1||PERFORMANCE:1||catheterization:1||Stones:1||Fistula sealant:1||Vesicovaginal fistula:1||urinary miRNA detection:1||LEUPROLIDE:1||diabetes mellitus:1||metabolic disease:1||Roboticassisted radical prostatectomy:1||kidney function:1||Female:1||

STATISTICS: Total View :6,091,341; Today View :3,492

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE